CLASS II Device recall · Reported 3 Jun 2020 · FDA Enforcement Report

Aptio Automation System with Advia2120LAS Interface Module recalled

Inpeco is recalling Aptio Automation System with Advia2120LAS Interface Module (, distributed nationwide in the US. The recall was initiated on 7 Apr 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial Numbers: AP2.0003 AP2.0007 AP2.0008 AP2.0009 AP2.0010 AP2.0017 AP2.0022 AP2.0025 AP2.0036 AP2.0049 AP2.0052 AP2.0057 AP2.0058 AP2.0059 AP2.0064 AP2.0065 AP2.0077 AP2.0082 AP2.0083 AP2.0089 AP2.0090 AP2.0092 AP2.0098 AP2.0100 AP2.0105 AP2.0109 AP2.0110 AP2.0129 AP2.0136 AP2.0149 AP2.0156 AP2.0173 AP2.0179 AP2.0180 AP2.0181 AP2.0193 AP2.0194 AP2.0201 AP2.0202 AP2.0211 AP2.0230 AP2.0233 AP2.0235 AP2.0236 AP2.0238 AP2.0251 AP2.0254 AP2.0258 AP2.0264 AP2.0269 AP2.0270 AP2.0275 AP2.0289 AP2.0295 AP2.0317 AP2.0325 AP2.0332 AP2.0339 AP2.0375 AP2.0381 AP2.0394 AP2.0411 AP2.0427 APT.0009 APT.0014 APT.0058 APT.0065 APT.0091 APT.0136 APT.0247
Quantity recalled70 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2142-2020
FDA event ID
85444
Recalling firm
Inpeco, Lugano, N/A
Classification
Class II
Status
Terminated
Recall initiated
7 Apr 2020
FDA classified
28 May 2020
Reported
3 Jun 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

7 Apr 2020Recall initiated by company
28 May 2020Classified by FDA+51 days
3 Jun 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Aptio Automation System with Advia2120LAS Interface Module (P/N FLX-219-00, FLX-219-10), ImmunoCAP 1000 Interface Module (P/N FLX-226-01, FLX-226-10), or StaRRsed Interface Module (P/N FLX-268-00) - Product Usage: is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The systems consolidate multiple Analytical instruments into a unified workstation.

Where it was distributed

US Nationwide including in the states of IL, NY.

Nationwide IllinoisNew York

Questions about this recall

Is Aptio Automation System with Advia2120LAS Interface Module ( recalled?

Yes. Inpeco recalled Aptio Automation System with Advia2120LAS Interface Module ( on 7 Apr 2020. The recall is Class II and its status is Terminated. Recall number Z-2142-2020.

Why was it recalled?

The identified problem is an erroneous association between the carrier and the sample tube caused by a communication error between the firmware of the Interface Modules and the Automation software. This problem can occur only when one of these Interface Modules is put off-line after a carrier in their secondary lane is physically returned on the main track and then put back on-line when the carrier is used to transport another tube.

Which lots are affected?

Serial Numbers: AP2.0003 AP2.0007 AP2.0008 AP2.0009 AP2.0010 AP2.0017 AP2.0022 AP2.0025 AP2.0036 AP2.0049 AP2.0052 AP2.0057 AP2.0058 AP2.0059 AP2.0064 AP2.0065 AP2.0077 AP2.0082 AP2.0083 AP2.0089 AP2.0090 AP2.0092 AP2.0098 AP2.0100 AP2.0105 AP2.0109 AP2.0110 AP2.0129 AP2.0136 AP2.0149 AP2.0156 AP2.0173 AP2.0179 AP2.0180 AP2.0181 AP2.0193 AP2.0194 AP2.0201 AP2.0202 AP2.0211 AP2.0230 AP2.0233 AP2.0235 AP2.0236 AP2.0238 AP2.0251 AP2.0254 AP2.0258 AP2.0264 AP2.0269 AP2.0270 AP2.0275 AP2.0289 AP2.0295 AP2.0317 AP2.0325 AP2.0332 AP2.0339 AP2.0375 AP2.0381 AP2.0394 AP2.0411 AP2.0427 APT.0009 APT.0014 APT.0058 APT.0065 APT.0091 APT.0136 APT.0247

Where was it sold?

US Nationwide including in the states of IL, NY.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Inpeco

All 33
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIFlexLab (FLX) recalled by InpecoInpecoOtherNationwide
DeviceCLASS IIFlexLab (FLX) recalled by InpecoInpecoOtherNationwide
DeviceCLASS IIFlexLab (FLX) System recalled by InpecoInpecoOtherCA, NY
DeviceCLASS IIFlexLab X (FXX) System recalled by InpecoInpecoOtherCA, NY
DeviceCLASS IIRoche Cobas 8000 and Cobas PRO Interface Module recalled by InpecoInpecoLead & Heavy MetalsNationwide

Other Other Medical Devices recalls

All 13,778